Tumor growth measurements demonstrated that ALDH1A3 knockout minimally reduced tumor growth in the immune compromised NSG mice compared to rescue while ALDH1A3 knockout led to a robust difference in the CD34-humanized mice (Figures 2D–2F). This evidence concerns the gene CD34 and neoplasm.